ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

In Brief: Construction Grant Application Deadline for 75-25% Funding Oct. 1; Fordham Quits

April 29, 1977

Construction, Pay Raise, Foundation Bills Clear Senate Committee

December 1, 1989

Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants

March 11, 1983

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000